Signaturefd LLC Buys 598 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Signaturefd LLC lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 34.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,334 shares of the exchange traded fund’s stock after acquiring an additional 598 shares during the period. Signaturefd LLC’s holdings in SPDR S&P Biotech ETF were worth $210,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the stock. Howard Capital Management Group LLC grew its position in SPDR S&P Biotech ETF by 2.6% in the third quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock valued at $24,514,000 after purchasing an additional 6,188 shares in the last quarter. Nwam LLC bought a new position in SPDR S&P Biotech ETF in the third quarter valued at $1,475,000. Clal Insurance Enterprises Holdings Ltd bought a new position in SPDR S&P Biotech ETF in the third quarter valued at $141,284,000. Great Valley Advisor Group Inc. grew its position in SPDR S&P Biotech ETF by 28.0% in the third quarter. Great Valley Advisor Group Inc. now owns 3,414 shares of the exchange traded fund’s stock valued at $337,000 after purchasing an additional 746 shares in the last quarter. Finally, Kingsview Wealth Management LLC grew its position in SPDR S&P Biotech ETF by 8.2% in the third quarter. Kingsview Wealth Management LLC now owns 3,962 shares of the exchange traded fund’s stock valued at $391,000 after purchasing an additional 299 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 0.6 %

SPDR S&P Biotech ETF stock opened at $87.12 on Friday. The company has a market cap of $5.65 billion, a P/E ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The company has a fifty day simple moving average of $89.59 and a 200 day simple moving average of $94.35.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.